Improving the Function Of XEN (iFOX) Study

Not Applicable

Recruiting

• Conditions: Glaucoma; Eye - Diseases / disorders of the eye

• Registration Number: ACTRN12619001364167
• Lead Sponsor: ions Eye Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-10-04
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 700

Inclusion Criteria

Patients with glaucoma (including primary open angle glaucoma, pseudoexfoliative glaucoma, chronic angle closure glaucoma as well as traumatic, uveitic, ICE and congenital glaucoma) who have undergone XEN gel stent implantation

Exclusion Criteria

Patients who have undergone glaucoma drainage device surgery (e.g. Baerveldt or Molteno tube) within 12 months following XEN surgery

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Post-operative change in intraocular pressure measured by Goldmann applanation tonometry[12 months post-operatively];Number of intraocular pressure lowering medications (eye drops) documented in medical records[12 months post-operatively]

Secondary Outcome Measures

Name	Time	Method
Bleb size and morphology (composite secondary outcome) based on the Indiana Bleb Grading Scale and documented in medical records[12 months post-operatively]